ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2%
Fri, 1 Nov

ALEMBIC PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m11,2719,48912,40930.8%10.1%
Other incomeRs m24334-89.0%-84.8%
TurnoverRs m11,2949,52212,41230.4%9.9%
ExpensesRs m8,2477,2408,95423.7%8.6%
Gross profitRs m3,0231,9643,45576.0%14.3%
DepreciationRs m2863543601.6%25.6%
InterestRs m58507142.0%21.8%
Profit before taxRs m2,7031,5933,02990.1%12.1%
TaxRs m70336052545.9%-25.3%
Profit after taxRs m2,0001,2332,504103.0%25.2%
Gross profit margin%26.820.727.8
Effective tax rate%26.022.617.3
Net profit margin%17.713.020.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 10.1% on a year-on-year (YoY) basis. The expenses were up by 8.6% YoY during the same period.
  • The company's operating profit increased by 14.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 2QFY20 as against 26.8% in 2QFY19.
  • Depreciation charges increased by 25.6% and finance costs increased by 21.8% YoY, respectively.
  • Other income declined by 84.8% YoY during the quarter.
  • Net profit for the quarter increased by 25.2% YoY. Net profit margins during the quarter increased from 17.7% in 2QFY19 to 20.2% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 30.8% on a quarter-on-quarter (QoQ) basis. The expenses were up by 23.7% QoQ during the same period.
  • The company's operating profit increased by 76.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 2QFY20 as against 20.7% in 1QFY19.
  • Net profit for the quarter increased by 103.0% QoQ, while net profit margins increased from 12.9% in 1QFY19 to 20.2% in 2QFY20.

To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.

Free Guide: Find the Next Crorepati Stock in this Futuristic Industry

ALEMBIC PHARMA Share Price Performance

Over the last one year,ALEMBIC PHARMA share price has moved down from Rs 601.6 to Rs 561.0, registering a Loss of Rs 40.6 or around 6.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,342.2 (up 0.9%). Over the last one year it has moved down from 14,632.9 to 13,342.2, a gain of 1,291 points (down 8.8%).

Overall, the S&P BSE SENSEX is up 16.6% over the year.

Current Valuations

At the current price of Rs 561.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 15.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.9 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Dec 13, 2019 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS